Fibrodysplasia Ossificans Progressiva (FOP) 接続レジストリ
FOP 接続: Fibrodysplasia Ossificans Progressiva コミュニティのグローバル レジストリ
The Fibrodysplasia Ossificans Progressiva (FOP) Registry is a global, non-interventional, voluntary database that captures demographic and disease data directly from FOP patients and their caregivers via a secure, web-based patient portal. A physician portal (in development) will allow physicians to enter clinical data about their patients. The objectives are to organize the international FOP community for participation in clinical trials; to enable FOP patients worldwide to report data in a shared forum; to improve the collective understanding of FOP natural history; and to advance the understanding of FOP treatment outcomes.
調査の概要
状態
状態
条件
条件
詳細な説明
The FOP Registry is a global, non-interventional, voluntary database that captures demographic and disease data directly from FOP patients and their caregivers via a secure, web-based patient portal. No experimental intervention is involved. The objectives are to organize the international FOP community for participation in clinical trials; to enable FOP patients worldwide to report data in a shared forum; to improve the collective understanding of FOP natural history; and to advance the understanding of FOP treatment outcomes.
The Registry collects data through two sources. First, the Patient Portal (launched in July 2015) allows FOP patients and caregivers to enter information about their experiences living with FOP. Second, the Physician Portal (in development) will allow physicians to enter clinical data about patients under their care. The Registry will be capable of including data on specific marketed therapies under the direction and control of a sponsoring pharmaceutical company. Key identifiers will link the physician-reported data with the Patient Portal data.
Participants must have a confirmed diagnosis of FOP and the participant (or a parent or legal guardian) must be willing and able to provide written informed consent. There are no exclusion criteria. Data collected in the Patient Portal include: patient demographics and diagnosis pathway; medical and dental care; clinical research participation and biospecimen donation; heterotopic ossification (bone growth and episodic flare-ups); other signs and symptoms by body system; patient-reported outcomes (physical functioning, pain, fatigue, and general health); and assistive devices, aids, attendants, and adaptations. Because the Registry is designed to accommodate participants along a broad spectrum of FOP disease severity, most of the data fields are optional, allowing participants a high degree of flexibility in how much information they contribute, which also minimizes participant burden.
After completing the informed consent, participants enter their baseline (historical) data. Participants will be encouraged to update their information at least twice per year. Participants may withdraw their consent at any time without prejudice or providing an explanation. The Registry has no pre-specified end date and will continue for as long as it is sustainable and useful to the FOP community.
研究の種類
研究の種類
入学 (推定)
入学
連絡先と場所
研究連絡先
研究連絡先
- 名前:Sammi Kile, MS
- 電話番号:1-720-341-6999
- メール:registry@ifopa.org
研究連絡先のバックアップ
- 名前:Mark Hamilton, PhD
- 電話番号:1-203-605-2122
- メール:mark.hamilton@ifopa.org
研究場所
-
-
Missouri
-
North Kansas City、Missouri、アメリカ、064116
- 募集
- The International Fibrodysplasia Ossificans Progressiva Association (IFOPA)
-
コンタクト:
- Sammi Kile, MS
- 電話番号:1-720-341-6999
- メール:registry@ifopa.org
-
コンタクト:
- Mark Hamilton, PhD
- 電話番号:1-203-605=2122
- メール:mark.hamilton@ifopa.org
-
-
参加基準
適格基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Individuals with Fibrodysplasia Ossificans Progressive (FOP) from the international FOP community will be invited to join the Registry.
説明
Inclusion Criteria:
- Participants must have a confirmed diagnosis of FOP.
- Participants (or a parent or legal guardian) must be willing and able to provide written informed consent.
Exclusion Criteria:
- There are no exclusion criteria.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:OTHER
- 時間の展望:PROSPECTIVE
グループ/コホートの数
コホートと介入
グループ/コホートグループ/コホート |
|---|
|
FOP Patients
None. IFOPA-REG-001 is a FOP patient observational registry study. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Patient Reported Changes in New Bone Growth Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report changes in new bone growth among 27 joints and body locations. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Episodic Flare-Ups Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report changes in episodic flare-ups among 27 joints and body locations. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Mobility Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report changes in mobility among 27 joints and body locations. |
Baseline, then every six months for up to 10 years
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Patient Reported Changes in Health Resource Utilization Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The number of visits to a Physician and a Dentist, as well as the number of hospitalizations and reasons for the hospitalizations, are used to assess health resource utilization. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Ear Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the ears. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Skin Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the skin. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Central Nervous System Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the central nervous system. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Pulmonary System Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the pulmonary system. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Gastrointestinal System Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the gastrointestinal system. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Cardiovascular System Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the cardiovascular system. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Renal System Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the renal system. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Endocrine System Using a Patient-Directed Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the endocrine system. |
Baseline, then every six months for up to 10 years
|
その他の成果指標
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
FOP-身体機能アンケート(PFQ)を使用して患者が報告した日常生活動作の変化
時間枠:ベースライン、その後 6 か月ごとに最大 10 年間
|
ベースライン、その後 6 か月ごとに最大 10 年間
|
|
|
PROMIS Global Health Scaleを使用して患者が全体的な健康状態の変化を報告
時間枠:ベースライン、その後 6 か月ごとに最大 10 年間
|
ベースライン、その後 6 か月ごとに最大 10 年間
|
|
|
Patient Reported Changes in the Need for Assistive Devices, Aids, Attendants, and Adaptations Using a Survey Developed by the IFOPA
時間枠:Baseline, then every six months for up to 10 years
|
The patient is able to respond Yes or No to questions related to his/her need for Assistive Devices, Aids, Attendants, and Adaptations as a result of his/her FOP disease. |
Baseline, then every six months for up to 10 years
|
協力者と研究者
捜査官
捜査官
- スタディディレクター:Mark Hamilton, PhD、International Fibrodysplasia Ossificans Progressiva Association
出版物と役立つリンク
便利なリンク
- <p>Click here for more information about this study: The FOP Connection Registry</p>
- <p>The International FOP Association is a 501(c)(3) non-profit organization supporting medical research, education and communication for those afflicted by the rare genetic condition Fibrodysplasia Ossificans Progressiva (FOP).</p>
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (推定)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- IFOPA-REG-001
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Formal data sharing agreements are planned between the International FOP Association and biopharmaceutical companies doing research in Fibrodysplasia Ossificans Progressiva (FOP). Publications are also planned with biopharmaceutical companies and physician researchers.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。